Prokidney (PROK) Operating Expenses (2021 - 2026)
Prokidney (PROK) posted quarterly Operating Expenses of $45.2 million for Q1 2026, up 8.51% year-over-year from $41.6 million in Q1 2025, and down 0.96% quarter-over-quarter from $45.6 million in Q4 2025.
Prokidney (PROK) Operating Expenses (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Operating Expenses for 6 consecutive years, with $45.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 8.51% year-over-year to $45.2 million; the TTM figure through Mar 2026 stood at $169.4 million (down 8.56% YoY), while the FY2025 annual figure was $165.9 million, down 9.72% from the prior year.
- Operating Expenses declined to $45.2 million in Q1 2026 per PROK's latest filing, from $45.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $66.5 million in Q1 2022 and bottomed at $20.7 million in Q2 2022.
- Historically, Operating Expenses has averaged $41.1 million across 5 years, with a median of $40.9 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 14501997.9% — and 2023, when it tumbled 38.5%.
- Prokidney's Operating Expenses stood at $30.2 million in 2022, then fell by 19.93% to $24.2 million in 2023, then surged by 113.33% to $51.6 million in 2024, then slipped by 11.72% to $45.6 million in 2025, then fell by 0.96% to $45.2 million in 2026.
- Business Quant data shows PROK's Operating Expenses at $45.2 million in Q1 2026, $45.6 million in Q4 2025, and $38.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Prokidney | 679.95 Mn | 679.95 Mn | - | 48.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.52 Mn |
| Mar 31, 2026 | 45.16 Mn |
| Dec 31, 2025 | 45.60 Mn |
| Sep 30, 2025 | 38.76 Mn |
| Jun 30, 2025 | 39.93 Mn |
| Mar 31, 2025 | 41.62 Mn |
| Dec 31, 2024 | 51.65 Mn |
| Sep 30, 2024 | 48.97 Mn |
| Jun 30, 2024 | 43.06 Mn |
| Mar 31, 2024 | 40.08 Mn |
| Dec 31, 2023 | 24.21 Mn |
| Sep 30, 2023 | 46.62 Mn |
| Jun 30, 2023 | 39.82 Mn |
| Mar 31, 2023 | 40.88 Mn |
| Dec 31, 2022 | 30.24 Mn |
| Sep 30, 2022 | 35.57 Mn |
| Jun 30, 2022 | 20.74 Mn |
| Mar 31, 2022 | 66.46 Mn |
| Dec 31, 2021 | 2.33 Mn |
| Sep 30, 2021 | 17.08 Mn |